Eribulin Mesylate
NDC 72603-368, Eribulin Mesylate, solution, from Northstar Rx LLC.
- Product NDC
- 72603-368
- Status
- Listed
- Labeler
- Northstar Rx LLC
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214850
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72603-368 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ERIBULIN MESYLATE.5 mg/mL
Pharmacologic classes
Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72603-368-01 | 72603036801 | 1 VIAL, SINGLE-DOSE in 1 CARTON (72603-368-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5caedc93-c3c4-45e5-a2c6-0ce069860584Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=72603-368
Use it
Look up 72603-368 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72603-368 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72603-368. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.